The child with acute leukemia.
D000367:Age Factors; D001215:Asparaginase / Q000009:adverse effects / Q000627:therapeutic use; D002644:Chickenpox / Q000175:diagnosis; D002675:Child, Preschool; D003376:Counseling; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000175:diagnosis; D003630:Daunorubicin / Q000627:therapeutic use; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D007278:Injections, Spinal; D007938:Leukemia / Q000175:diagnosis / Q000188:drug therapy; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use; D010347:Patient Care Planning; D010372:Pediatrics; D010817:Physician-Patient Relations; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use; D011379:Prognosis; D012737:Sex Factors; D014750:Vincristine / Q000009:adverse effects / Q000627:therapeutic use
D003561:Cytarabine; D014750:Vincristine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D001215:Asparaginase; D011241:Prednisone; D008727:Methotrexate; D003630:Daunorubicin